About: Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on October 2010

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2010 (ast) наукова стаття, опублікована в жовтні 2010 (uk) مقالة علمية نشرت في أكتوبر 2010 (ar) scientific article published on October 2010 (en)
publication date	wds:Q37800999-39F5513A-CC68-4847-BE15-7E3FDCCCDA18
publication date	2010-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37800999-6260D68B-028C-4465-9221-EE4810F7E76D
language of work or name	English
cites work	wds:Q37800999-13FC91EB-9AE9-4D47-B796-871B8CBF8E59 wds:Q37800999-67DE3F61-0CDA-4CF8-802C-AC4A4B01D322 wds:Q37800999-85BC1D32-731D-47EB-98EE-071FBC01EC90 wds:Q37800999-CA9C50B4-9609-4FBA-98F5-84A43F498E9D wds:Q37800999-FCC5F318-0145-4A68-877E-FD5F0381B67B
cites work	Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Inflammatory mechanisms after ischemia and stroke Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion
author name string	wds:Q37800999-0CBCAE37-EC5A-4C72-90F6-FD856F6D81CF wds:Q37800999-1D4EF020-DDD8-49F8-A1C7-9186D989E21A wds:Q37800999-87D0B66A-BFFC-41E4-ADA2-95A4C2E2F92A wds:Q37800999-B80332C0-CE8E-4266-A6D2-FE1DBEF1C3BE
author name string	Joan Montaner Anna Morancho Anna Rosell Lidia García-Bonilla
rdfs:label	Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (en) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (nl) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (ast)
skos:prefLabel	Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (en) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (nl) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (ast)
name	Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (en) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (nl) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (ast)
title	wds:Q37800999-CEA7F825-A679-4E20-A3DB-E19C48A9D1B1
title	Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (en)
page(s)	wds:Q37800999-59AEA154-3777-4394-9EA8-2130A7A5AB73
page(s)	123-133
instance of	wds:Q37800999-A80230EA-33A6-4995-82B8-20941CBD421D
instance of	scholarly article
main subject	wds:Q37800999-BA5909D1-7575-4F2B-AC53-BDFF13781E8D
main subject	inflammation
PubMed ID	wds:Q37800999-E9493E91-B69A-44E8-BE96-105040C73B16
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20955435
PubMed ID	20955435
published in	wds:Q37800999-1E2BE089-61DD-4D3F-8C39-7EFF37A9C73C
published in	Annals of the New York Academy of Sciences
volume	wds:Q37800999-5A6B8631-868A-444D-AB7E-03F0B00B31D7
volume	1207
DOI	wds:Q37800999-AF3002FB-2EAC-42B1-83AA-EABB53DF92F3
DOI	http://dx.doi.org/10.1111/J.1749-6632.2010.05734.X
DOI	10.1111/J.1749-6632.2010.05734.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37800999
is cites work of	Is there new hope for therapeutic matrix metalloproteinase inhibition? Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mice Stroke and the immune system: from pathophysiology to new therapeutic strategies Crosstalk between cerebral endothelium and oligodendrocyte Mmp-9 inhibition: a therapeutic strategy in ischemic stroke Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! Matrix metalloproteinase-9 expression in the nuclear compartment of neurons and glial cells in aging and stroke The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders Dissecting the association between migraine and stroke Matrix metalloproteinase-9 concentration in the cerebral extracellular fluid of patients during the acute phase of aneurysmal subarachnoid hemorrhage Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke Post-ischemic inflammation in the brain Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia Developmental and pathological angiogenesis in the central nervous system Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial. Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury 2-Chloroethanol Induced Upregulation of Matrix Metalloproteinase-2 in Primary Cultured Rat Astrocytes Via MAPK Signal Pathways Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways Does inhibiting Sur1 complement rt-PA in cerebral ischemia? Impaired vascular remodeling after endothelial progenitor cell transplantation in MMP9-deficient mice suffering cortical cerebral ischemia Mild hypothermia reduces expression of Fas/FasL and MMP-3 after cerebral ischemia-reperfusion in rats Thrombin Enhanced Matrix Metalloproteinase-9 Expression and Migration of SK-N-SH Cells via PAR-1, c-Src, PYK2, EGFR, Erk1/2 and AP-1. Interrelations between blood-brain barrier permeability and matrix metalloproteinases are differently affected by tissue plasminogen activator and hyperoxia in a rat model of embolic stroke Inhibiting High-Mobility Group Box 1 (HMGB1) Attenuates Inflammatory Cytokine Expression and Neurological Deficit in Ischemic Brain Injury Following Cardiac Arrest in Rats. Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice. Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke. Microcystin-Leucine Arginine Causes Cytotoxic Effects in Sertoli Cells Resulting in Reproductive Dysfunction in Male Mice Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software